Open letter to Doctor Nicolas Dauby
An expert for the Task Force Therapeutics (which assesses the relevance of medicine purchases), the FAMHP (Federal Agency for Medicines and Health Products) and the EMA (European Medicines Agency), Dr Nicolas Dauby collects conflicts of interest[1].
In an open letter, Dr Alain Colignon looks back at the curious change made by Dr Dauby in April 2022.
|
|
The opinions expressed in this opinion piece are solely those of its author and do not necessarily reflect those of BAM!
Standfirst and illustration by BAM!




